Correction of Diabetic Erectile Dysfunction with Adipose Derived Stem Cells Modified with the Vascular Endothelial Growth Factor Gene in a Rodent Diabetic Model

• DOI: 10.1371/journal.pone.0072790
• Publication Date: 2013-08-30T21:24:23Z
• Authors: Guihua Liu; Xiangzhou Sun; Jun Bian; Rongpei Wu; Xuan Guan; Bin Ouyang; Yanping Huang; Haipeng Xiao; Daosheng Luo; Anthony Atala; Yuanyuan Zhang; Chunhua Deng
• Keywords: Blood Glucose; Male; 0301 basic medicine; Nitric Oxide Synthase Type III; Science; Myocytes, Smooth Muscle; Diabetes Complications; Rats, Sprague-Dawley; 03 medical and health sciences; Erectile Dysfunction; Animals; Humans; Cells, Cultured; Q; Body Weight; R; Endothelial Cells; Genetic Therapy; Rats; 3. Good health; Disease Models, Animal; Receptors, Vascular Endothelial Growth Factor; Adipose Tissue; Medicine; Pericytes; Biomarkers; Research Article; Stem Cell Transplantation

The aim of this study was to determine whether adipose derived stem cells (ADSCs) expressing vascular endothelial growth factor (VEGF) gene can improve endothelial function, recover the impaired VEGF signaling pathway and enhance smooth muscle contents in a rat diabetic erectile dysfunction (DED) model. DED rats were induced via intraperitoneal injection of streptozotocin (40 mg/kg), and then screened by apomorphine (100 µg/kg). Five groups were used (n = 12/group)-Group 1 (G1): intracavernous injection of lentivirus-VEGF; G2: ADSCs injection; G3: VEGF-expressing ADSCs injection; G4: Phosphate buffered saline injection; G1-G4 were DED rats; G5: normal rats. The mean arterial pressure (MAP) and intracavernosal pressure (ICP) were measured at days 7 and 28 after the injections. The components of the VEGF system, endothelial, smooth muscle, pericytes markers in cavernoursal tissue were assessed. On day 28 after injection, the group with intracavernosum injection of ADSCs expressing VEGF displayed more efficiently and significantly raised ICP and ICP/MAP (p<0.01) than those with ADSCs or lentivirus-VEGF injection. Western blot and immunofluorescent analysis demonstrated that improved erectile function by ADSCs-VEGF was associated with increased expression of endothelial markers (VEGF, VEGF R1, VEGF R2, eNOS, CD31 and vWF), smooth muscle markers (a-actin and smoothelin), and pericyte markers (CD146 and NG2). ADSCs expressing VEGF produced a therapeutic effect and restored erectile function in diabetic rats by enhancing VEGF-stimulated endothelial function and increasing the contents of smooth muscle and pericytes.